Drug Shortage Report for IMITREX
Report ID | 161830 |
Drug Identification Number | 02212188 |
Brand name | IMITREX |
Common or Proper name | Sumatriptan succinate injection |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 6MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 2x0.5mL |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-01 |
Estimated end date | 2022-08-05 |
Actual end date | 2022-07-29 |
Shortage status | Resolved |
Updated date | 2022-07-30 |
Company comments | Limited supply currently available. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-07-30 | English | Compare |
v9 | 2022-07-29 | French | Compare |
v8 | 2022-07-29 | English | Compare |
v7 | 2022-07-29 | English | Compare |
v6 | 2022-06-29 | French | Compare |
v5 | 2022-06-29 | English | Compare |
v4 | 2022-06-22 | French | Compare |
v3 | 2022-06-22 | English | Compare |
v2 | 2022-06-03 | French | Compare |
v1 | 2022-06-03 | English | Compare |
Showing 1 to 10 of 10